Fair value inputs probability of occurrence.

No definition available.

Name:	abmd_FairValueInputsProbabilityOfOccurrence
Namespace Prefix:	abmd_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value inputs probability of payment under risk neutral.

+ References

No definition available.

+ Details

Name:	abmd_FairValueInputsProbabilityOfPaymentUnderRiskNeutral
Namespace Prefix:	abmd_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value inputs year of payments.

+ References

No definition available.

+ Details

Name:	abmd_FairValueInputsYearOfPayments
Namespace Prefix:	abmd_
Data Type:	xbrli:gYearItemType
Balance Type:	na
Period Type:	duration

- Definition

Milestone payment.

+ References

No definition available.

+ Details

Name:	abmd_MilestonePayment
Namespace Prefix:	abmd_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Value of input used to measure alternative investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_AlternativeInvestmentMeasurementInput
Namespace Prefix:	us-gaap_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph b
-URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=abmd_EcpEntwickslungsgesellschaftMbhMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=abmd_ClinicalAndRegulatoryMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByLiabilityClassAxis=abmd_ContingentConsiderationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	abmd_ProbabilityAdjustmentLevelAxis=abmd_VariousMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	abmd_ProbabilityAdjustmentLevelAxis=abmd_BaseCaseScenarioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=abmd_MonteCarloSimulationModelMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=abmd_RevenueBasedMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Valuation Method Used to Calculate Level 3 Liabilities Measured at Estimated Fair Value of Contingent Consideration (Detail) $ in Thousands	12 Months Ended
	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	$ 9,000	$ 9,575
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	9,000	$ 9,575
Level 3 \| ECP Entwicklungsgesellschaft mbH
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Milestone Payment	15,000
Contingent consideration	9,000
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Milestone Payment	7,000
Contingent consideration	$ 5,362
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Contingent Consideration \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Projected fiscal year of milestone payments	2022
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Contingent Consideration \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Projected fiscal year of milestone payments	2024
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Various Downside and Upside Scenarios \| Contingent Consideration \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of occurrence	5.00%
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Various Downside and Upside Scenarios \| Contingent Consideration \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of occurrence	40.00%
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Base Case Scenario \| Contingent Consideration
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of occurrence	40.00%
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Base Case Scenario \| Contingent Consideration \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Projected fiscal year of milestone payments	2026
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Base Case Scenario \| Contingent Consideration \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Projected fiscal year of milestone payments	2035
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Discount Rate \| Contingent Consideration \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	0.0372
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Probability weighted income approach \| Clinical and regulatory milestone \| Discount Rate \| Contingent Consideration \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	0.0390
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Monte Carlo simulation model \| Revenue-based milestone
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Milestone Payment	$ 8,000
Contingent consideration	$ 3,638
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Monte Carlo simulation model \| Revenue-based milestone \| Contingent Consideration
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of payment (risk neutral)	62.70%
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Monte Carlo simulation model \| Revenue-based milestone \| Discount Rate \| Contingent Consideration
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	0.15
Level 3 \| ECP Entwicklungsgesellschaft mbH \| Monte Carlo simulation model \| Revenue-based milestone \| Measurement Input, Price Volatility \| Contingent Consideration
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative investment, measurement input	0.50